Literature DB >> 25147111

2003-2013: a decade of body mass index, Alzheimer's disease, and dementia.

Tim L Emmerzaal1, Amanda J Kiliaan1, Deborah R Gustafson2.   

Abstract

The occurrence of obesity, commonly estimated using body mass index (BMI), and the most common late-onset dementia, Alzheimer's disease (AD), are increasing globally. The year 2013 marked a decade of epidemiologic observational reports on the association between BMI and late-onset dementias. In this review, we highlight epidemiological studies that measured both mid- and late-life BMI in association with dementia. Studies investigating the association between midlife BMI and risk for dementia demonstrated generally an increased risk among overweight and obese adults. When measured in late-life, elevated BMI has been associated with lower risk. In addition, being underweight and/or having a decrease in BMI in late-life are associated with higher dementia risk compared to BMI in the normal range or stable BMI. In this review, a decade (2003-2013) of epidemiologic observational studies on associations between BMI and AD is highlighted. These observations provide a strong base for addressing biological mechanisms underlying this complex association.

Entities:  

Keywords:  Alzheimer's disease; body mass index; dementia; epidemiology; obesity; overweight

Mesh:

Year:  2015        PMID: 25147111     DOI: 10.3233/JAD-141086

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  96 in total

1.  A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Michael Malek-Ahmadi; Sarah E Monsell; Walter A Kukull; Bryan K Woodruff; Eric M Reiman; Thomas G Beach; Jeffrey Wilson
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

2.  Association of body mass index and waist-to-hip ratio with brain structure: UK Biobank study.

Authors:  Mark Hamer; G David Batty
Journal:  Neurology       Date:  2019-01-09       Impact factor: 9.910

3.  Distinct age-related associations for body mass index and cognition in cognitively healthy very old veterans.

Authors:  James Schmeidler; Cecilia N Mastrogiacomo; Michal S Beeri; Clive Rosendorff; Jeremy M Silverman
Journal:  Int Psychogeriatr       Date:  2019-02-05       Impact factor: 3.878

4.  Adiposity, Change in Adiposity, and Cognitive Decline in Mid- and Late Life.

Authors:  Nancy A West; Seth T Lirette; Victoria A Cannon; Stephen T Turner; Thomas H Mosley; Beverly G Windham
Journal:  J Am Geriatr Soc       Date:  2017-03-01       Impact factor: 5.562

Review 5.  Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.

Authors:  Bart A A Franx; Ilse A C Arnoldussen; Amanda J Kiliaan; Deborah R Gustafson
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

6.  Primary prevention of dementia: from modifiable risk factors to a public brain health agenda?

Authors:  Felix S Hussenoeder; Steffi G Riedel-Heller
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-09-25       Impact factor: 4.328

Review 7.  'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.

Authors:  Laura M Pérez; Helios Pareja-Galeano; Fabián Sanchis-Gomar; Enzo Emanuele; Alejandro Lucia; Beatriz G Gálvez
Journal:  J Physiol       Date:  2016-05-10       Impact factor: 5.182

8.  A spectrum of contributions of type 2 diabetes and related metabolic characteristics to dementia.

Authors:  Ramit Ravona-Springer; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-12       Impact factor: 4.600

9.  Effects of aging, high-fat diet, and testosterone treatment on neural and metabolic outcomes in male brown Norway rats.

Authors:  V Alexandra Moser; Amy Christensen; Jiahui Liu; Amanda Zhou; Shunya Yagi; Christopher R Beam; Liisa Galea; Christian J Pike
Journal:  Neurobiol Aging       Date:  2018-09-22       Impact factor: 4.673

10.  Neuroprotective potential of the oxindole alkaloids isomitraphylline and mitraphylline in human neuroblastoma SH-SY5Y cells.

Authors:  Mario A Tan; Seong Soo A An
Journal:  3 Biotech       Date:  2020-11-09       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.